1
Frederick P Chlanda, Lester T C Lee, Kang Jen Liu: Bipolar membranes and method of making same. Allied Chemical Corporation, Arthur J Plantamura, Ernest A Polin, Thomas D Hoffman, September 26, 1978: US04116889 (90 worldwide citation)

Stable bipolar membranes of high permselectivity and low potential drop are prepared using either an anion or cation preformed first layer upon which a second layer or coating of an ion exchange resin of the opposite charge carried in a matrix polymer is applied. The second layer may be suitably app ...


2
Julianne Fassberg, Joel A Sequeira, Imtiaz A Chaudry, Michael Kopcha: Non-chlorofluorocarbon aerosol formulations. Schering Corporation, Edward H Mazer, Thomas D Hoffman, Robert A Franks, December 12, 1995: US05474759 (84 worldwide citation)

Aerosol formulations substantially free of chlorofluorocarbons for oral and/or nasal administration are described. The formulations comprise 1,1,1,2,3,3,3-heptafluoropropane, a medicament, optionally an excipient and optionally a surfactant. Methods of treatment utilizing the formulations are also d ...


3
Robert J Edmundson, Terry C Jacks: High-gloss, high-shine lipstick. Plough, Thomas D Hoffman, Gerald S Rosen, October 10, 1989: US04873078 (69 worldwide citation)

A lipstick composition comprising a gloss-enhancing amount i.e. about 0.5 to about 8 weight percent of isohexadecane in a conventional lipstick formulation is disclosed.


4
Gary M Skwarek, Stephen J Morfit: Applicator for semisolid medications. Schering Plough HealthCare Products, Robert A Franks, Thomas D Hoffman, Eric S Dicker, July 2, 1996: US05531703 (68 worldwide citation)

An applicator 10 includes a barrel 12 for containing a semisolid medicinal, the barrel including a large diameter cylindrical section 16, a small diameter cylindrical section 18 and an annular sloped transition section 20 that connects the large diameter cylindrical section and the small diameter cy ...


5
Farah J Munayyer, Joel A Sequeira: Stable cream and lotion bases for lipophilic drug compositions. Schering Corporation, Thomas D Hoffman, June 6, 1995: US05422361 (66 worldwide citation)

A cosmetically elegant, physically and chemically stable base in the form of an oil-in-water emulsion for use in cream and lotion lipophilic drug containing- pharmaceutical compositions containing at least one lipophilic drug and an effective amount of N-methyl-2-pyrrolidone is disclosed.


6
Paul R Gifford, Lawrence W Shacklette, James E Toth, James F Wolf: Secondary batteries using room-temperature molten non-aqueous electrolytes containing 1,2,3-trialkylimidazolium halides or 1,3-dialkylimidazolium halide. Allied Corporation, Alan M Doernberg, Gerhard H Fuchs, Thomas D Hoffman, July 31, 1984: US04463071 (65 worldwide citation)

Batteries and especially secondary batteries employing selected anodes and cathodes such as conjugated backbone polymers and transition metal chalcogenides inserted with alkali metal cations (especially lithium) and molten, non-aqueous electrolyte compositions containing admixture of aluminum halide ...


7
Janice K Albrecht: Combination therapy for eradicating detectable HCV-RNA in patients having chronic Hepatitis C infection. Schering Corporation, Thomas D Hoffman, James R Nelson, January 9, 2001: US06172046 (65 worldwide citation)

There is disclosed a method for treating a patient having chronic hepatitis C infection to eradicate detectable HCV-RNA involving a combination therapy using a therapeutically effective amount of ribavirin and a therapeutically effective amount of interferon-alpha for a time period of from 20 up to ...


8
Janice K Albrecht: Combination therapy for eradicating detectable HCV-RNA in antiviral treatment naive patients having chronic hepatitis C infection. Schering Corporation, Thomas D Hoffman, October 29, 2002: US06472373 (61 worldwide citation)

Methods for treating an antiviral treatment naive patient having chronic hepatitis C infection to eradicate detectable HCV-RNA involving administering a therapeutically effective amount of a combination therapy of ribavirin and interferon-alpha for a time period of from 20 up to 50 weeks are disclos ...


9
Alan B Gancy, Theodore J Jenczewski: Electrodialytic process for the conversion of impure soda values to sodium hydroxide and carbon dioxide. Allied Chemical Corporation, Thomas D Hoffman, Ernest A Polin, December 9, 1980: US04238305 (55 worldwide citation)

An electrodialytic process for the conversion of soda sources containing anionic and optionally nonionic impurities to high purity, high strength sodium hydroxide and carbon dioxide gas is disclosed.


10
Paul R Gifford, James B Palmisano, Lawrence W Shacklette, Ronald R Chance, James E Toth: Secondary batteries containing room-temperature molten 1,2,3-trialkylimidazolium halide non-aqueous electrolyte. Allied Corporation, Alan M Doernberg, Gerhard H Fuchs, Thomas D Hoffman, July 31, 1984: US04463072 (54 worldwide citation)

Batteries and especially secondary batteries employing an anode comprising aluminum and a molten, non-aqueous electrolyte containing admixtures of aluminum halide and 1,2,3-trialkylimidazolium halides having the formula TimX: ##STR1## wherein R.sub.1, R.sub.2 and R.sub.3 are independently alkyl grou ...